{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,28]],"date-time":"2026-08-28T23:52:27Z","timestamp":1787961147727,"version":"build-2784847793"},"reference-count":68,"publisher":"American Society for Microbiology","issue":"2","license":[{"start":{"date-parts":[[2026,2,11]],"date-time":"2026-02-11T00:00:00Z","timestamp":1770768000000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"},{"start":{"date-parts":[[2026,2,11]],"date-time":"2026-02-11T00:00:00Z","timestamp":1770768000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/journals.asm.org\/non-commercial-tdm-license"}],"funder":[{"DOI":"10.13039\/501100008530","name":"European Regional Development Fund","doi-asserted-by":"publisher","award":["515454"],"award-info":[{"award-number":["515454"]}],"id":[{"id":"10.13039\/501100008530","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100022019","name":"Qbiotics","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100022019","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["journals.asm.org"],"crossmark-restriction":true},"short-container-title":["mBio"],"published-print":{"date-parts":[[2026,2,11]]},"abstract":"<jats:title>ABSTRACT<\/jats:title>\n                  <jats:sec>\n                    <jats:title\/>\n                    <jats:p>\n                      The unrestricted use of colistin in animal husbandry has led to the emergence of mobile plasmid-borne colistin resistance (\n                      <jats:italic toggle=\"yes\">mcr<\/jats:italic>\n                      ). The antimicrobial epoxytigliane, EBC-1013, has been shown to be effective in the topical treatment of biofilm-mediated infections\n                      <jats:italic toggle=\"yes\">in vivo<\/jats:italic>\n                      . Hypothesizing that EBC-1013 interacts with the modified bacterial outer membrane of colistin-resistant\n                      <jats:italic toggle=\"yes\">Escherichia coli,<\/jats:italic>\n                      we investigated its ability to potentiate the activity of colistin using fractional inhibitory concentration (FIC) index determinations against environmental\n                      <jats:italic toggle=\"yes\">mcr<\/jats:italic>\n                      Enterobacteriaceae. Molecular dynamics (MD) simulations were used to visualize EBC-1013 interactions with the outer membrane\n                      <jats:italic toggle=\"yes\">in silico<\/jats:italic>\n                      . Modification of outer membrane surface chemistry and adhesion properties was characterized using X-ray photoelectron spectroscopy (XPS) and hydrophobicity and bacterial membrane permeability assays. Anti-biofilm activity was quantified using confocal laser scanning microscopy (CLSM). Checkerboard assays revealed synergistic effects of EBC-1013 with colistin (FIC \u2264 0.5) in 6\/9 strains. MD simulations demonstrated weak EBC-1013 interactions with colistin and the outer membrane. XPS suggested modification of the outer membrane in both colistin-sensitive and colistin-resistant\n                      <jats:italic toggle=\"yes\">E. coli,<\/jats:italic>\n                      as well as the interaction of colistin and EBC-1013 with the phosphoethanolamine (pEtN)-substituted\n                      <jats:italic toggle=\"yes\">mcr<\/jats:italic>\n                      lipid moiety. EBC-1013 binding significantly decreased bacterial hydrophilicity and potentiated membrane permeability induced by colistin (\n                      <jats:italic toggle=\"yes\">P<\/jats:italic>\n                      &lt; 0.05). In the biofilm model, potentiation was also evident, with a marked decrease in bacterial biomass in EBC-1013\/colistin combined treatments (\n                      <jats:italic toggle=\"yes\">P<\/jats:italic>\n                      &lt; 0.0001) for colistin-resistant\n                      <jats:italic toggle=\"yes\">E. coli<\/jats:italic>\n                      . The results highlight the ability of EBC-1013 to modify the bacterial membrane of colistin-resistant\n                      <jats:italic toggle=\"yes\">E. coli<\/jats:italic>\n                      and potentiate the activity of colistin in the treatment of multidrug-resistant wound bacteria.\n                    <\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>IMPORTANCE<\/jats:title>\n                    <jats:p>\n                      Resistance to colistin, an antibiotic of last resort for hard-to-treat infections, is on the increase. Therefore, the need to develop new antimicrobials to tackle antimicrobial resistance is of paramount importance. The epoxytiglianes represent an exciting range of molecules with a diverse range of biological effects in human and veterinary applications, including antimicrobial properties. In this study, we show how EBC-1013 interacts with the outer surface of colistin-resistant\n                      <jats:italic toggle=\"yes\">Escherichia coli<\/jats:italic>\n                      cells, inducing chemical and structural changes to the cell wall, making it susceptible again to colistin treatment. This ability of EBC-1013 to enhance the activity of colistin against a range of colistin-resistant\n                      <jats:italic toggle=\"yes\">E. coli<\/jats:italic>\n                      suggests that EBC-1013, alone (or as a combination therapy), has potential as a new treatment strategy to treat antibiotic-resistant bacterial wound infections and reduce antibiotic usage.\n                    <\/jats:p>\n                    <jats:p>\n                      This study is registered with ClinicalTrials.gov as (Australian New Zealand Clinical Trials Register:\n                      <jats:ext-link xmlns:xlink=\"http:\/\/www.w3.org\/1999\/xlink\" ext-link-type=\"uri\" xlink:href=\"https:\/\/www.anzctr.org.au\/Trial\/Registration\/TrialReview.aspx?ACTRN=12624000544572p\" xlink:type=\"simple\">ACTRN12624000544572<\/jats:ext-link>\n                      ).\n                    <\/jats:p>\n                  <\/jats:sec>","DOI":"10.1128\/mbio.02314-25","type":"journal-article","created":{"date-parts":[[2025,12,29]],"date-time":"2025-12-29T13:00:26Z","timestamp":1767013226000},"update-policy":"https:\/\/doi.org\/10.1128\/asmj-crossmark-policy-page","source":"Crossref","is-referenced-by-count":1,"title":["Epoxytiglianes potentiate the activity of colistin against resistant\n                    <i>Escherichia coli<\/i>\n                    via modification of the bacterial cell membrane"],"prefix":"10.1128","volume":"17","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-5135-4744","authenticated-orcid":true,"given":"Manon F.","family":"Pritchard","sequence":"first","affiliation":[{"id":[{"id":"https:\/\/ror.org\/03kk7td41","id-type":"ROR","asserted-by":"publisher"}],"name":"Advanced Therapies Group, School of Dentistry, Cardiff University","place":["Cardiff, United Kingdom"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-6842-1288","authenticated-orcid":false,"given":"Wenya","family":"Xue","sequence":"additional","affiliation":[{"id":[{"id":"https:\/\/ror.org\/03kk7td41","id-type":"ROR","asserted-by":"publisher"}],"name":"Advanced Therapies Group, School of Dentistry, Cardiff University","place":["Cardiff, United Kingdom"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0009-0008-8907-7368","authenticated-orcid":false,"given":"Jingxiang","family":"Wu","sequence":"additional","affiliation":[{"id":[{"id":"https:\/\/ror.org\/03kk7td41","id-type":"ROR","asserted-by":"publisher"}],"name":"Advanced Therapies Group, School of Dentistry, Cardiff University","place":["Cardiff, United Kingdom"]},{"id":[{"id":"https:\/\/ror.org\/00rd5t069","id-type":"ROR","asserted-by":"publisher"}],"name":"Department of Implantology, School and Hospital of Stomatology, Wenzhou Medical University","place":["Wenzhou, China"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0009-0005-9917-061X","authenticated-orcid":false,"given":"Francesca","family":"Boardman","sequence":"additional","affiliation":[{"id":[{"id":"https:\/\/ror.org\/03kk7td41","id-type":"ROR","asserted-by":"publisher"}],"name":"Advanced Therapies Group, School of Dentistry, Cardiff University","place":["Cardiff, United Kingdom"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0009-0008-6013-9211","authenticated-orcid":false,"given":"Mei","family":"Li","sequence":"additional","affiliation":[{"id":[{"id":"https:\/\/ror.org\/052gg0110","id-type":"ROR","asserted-by":"publisher"}],"name":"Ineos Oxford Institute for Antimicrobial Research, University of Oxford","place":["Oxford, United Kingdom"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0009-0003-3613-4027","authenticated-orcid":false,"given":"Yuqing","family":"Zhou","sequence":"additional","affiliation":[{"id":[{"id":"https:\/\/ror.org\/052gg0110","id-type":"ROR","asserted-by":"publisher"}],"name":"Ineos Oxford Institute for Antimicrobial Research, University of Oxford","place":["Oxford, United Kingdom"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-3284-3198","authenticated-orcid":false,"given":"Saira","family":"Khan","sequence":"additional","affiliation":[{"id":[{"id":"https:\/\/ror.org\/03kk7td41","id-type":"ROR","asserted-by":"publisher"}],"name":"Advanced Therapies Group, School of Dentistry, Cardiff University","place":["Cardiff, United Kingdom"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-8641-0160","authenticated-orcid":false,"given":"Lydia C.","family":"Powell","sequence":"additional","affiliation":[{"id":[{"id":"https:\/\/ror.org\/03kk7td41","id-type":"ROR","asserted-by":"publisher"}],"name":"Advanced Therapies Group, School of Dentistry, Cardiff University","place":["Cardiff, United Kingdom"]},{"id":[{"id":"https:\/\/ror.org\/053fq8t95","id-type":"ROR","asserted-by":"publisher"}],"name":"Microbiology and Infectious Disease Group, Swansea University Medical School, Swansea University","place":["Swansea, United Kingdom"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-8836-4209","authenticated-orcid":true,"given":"Joana","family":"Stokniene","sequence":"additional","affiliation":[{"name":"QBiotics Group Ltd.","place":["Yungaburra, Australia"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-9967-5467","authenticated-orcid":false,"given":"Josh","family":"Davies-Jones","sequence":"additional","affiliation":[{"id":[{"id":"https:\/\/ror.org\/03kk7td41","id-type":"ROR","asserted-by":"publisher"}],"name":"School of Chemistry, Cardiff Catalysis Institute, Cardiff University","place":["Cardiff, United Kingdom"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-4394-766X","authenticated-orcid":false,"given":"Philip R.","family":"Davies","sequence":"additional","affiliation":[{"id":[{"id":"https:\/\/ror.org\/03kk7td41","id-type":"ROR","asserted-by":"publisher"}],"name":"School of Chemistry, Cardiff Catalysis Institute, Cardiff University","place":["Cardiff, United Kingdom"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-0260-5057","authenticated-orcid":false,"given":"Niklaas J.","family":"Buurma","sequence":"additional","affiliation":[{"id":[{"id":"https:\/\/ror.org\/03kk7td41","id-type":"ROR","asserted-by":"publisher"}],"name":"Physical Organic Chemistry Centre, School of Chemistry, Cardiff University","place":["Cardiff, United Kingdom"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-6600-6507","authenticated-orcid":false,"given":"Georgina E.","family":"Menzies","sequence":"additional","affiliation":[{"id":[{"id":"https:\/\/ror.org\/03kk7td41","id-type":"ROR","asserted-by":"publisher"}],"name":"School of Biosciences, Cardiff University","place":["Cardiff, United Kingdom"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-9117-6911","authenticated-orcid":false,"given":"Owen B.","family":"Spiller","sequence":"additional","affiliation":[{"name":"Medical Microbiology, School of Medicine, Cardiff University","place":["Cardiff, United Kingdom"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-4315-4096","authenticated-orcid":false,"given":"Timothy R.","family":"Walsh","sequence":"additional","affiliation":[{"id":[{"id":"https:\/\/ror.org\/052gg0110","id-type":"ROR","asserted-by":"publisher"}],"name":"Ineos Oxford Institute for Antimicrobial Research, University of Oxford","place":["Oxford, United Kingdom"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-0993-8957","authenticated-orcid":false,"given":"Paul","family":"Reddell","sequence":"additional","affiliation":[{"name":"QBiotics Group Ltd.","place":["Yungaburra, Australia"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-8590-0117","authenticated-orcid":true,"given":"Katja E.","family":"Hill","sequence":"additional","affiliation":[{"id":[{"id":"https:\/\/ror.org\/03kk7td41","id-type":"ROR","asserted-by":"publisher"}],"name":"Advanced Therapies Group, School of Dentistry, Cardiff University","place":["Cardiff, United Kingdom"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-7319-5820","authenticated-orcid":false,"given":"David W.","family":"Thomas","sequence":"additional","affiliation":[{"id":[{"id":"https:\/\/ror.org\/03kk7td41","id-type":"ROR","asserted-by":"publisher"}],"name":"Advanced Therapies Group, School of Dentistry, Cardiff University","place":["Cardiff, United Kingdom"]}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"235","reference":[{"key":"e_1_3_4_2_2","doi-asserted-by":"publisher","DOI":"10.1080\/22221751.2020.1754133"},{"key":"e_1_3_4_3_2","doi-asserted-by":"publisher","DOI":"10.1016\/j.idc.2020.08.003"},{"key":"e_1_3_4_4_2","doi-asserted-by":"publisher","DOI":"10.1016\/S1473-3099(15)00424-7"},{"key":"e_1_3_4_5_2","doi-asserted-by":"publisher","DOI":"10.1128\/mBio.00853-19"},{"key":"e_1_3_4_6_2","doi-asserted-by":"publisher","DOI":"10.1080\/1040841X.2018.1492902"},{"key":"e_1_3_4_7_2","doi-asserted-by":"publisher","DOI":"10.1080\/22221751.2020.1732231"},{"key":"e_1_3_4_8_2","doi-asserted-by":"publisher","DOI":"10.1128\/mBio.00543-17"},{"key":"e_1_3_4_9_2","doi-asserted-by":"publisher","DOI":"10.1038\/s41396-019-0578-6"},{"key":"e_1_3_4_10_2","doi-asserted-by":"publisher","DOI":"10.1128\/JCM.01454-18"},{"key":"e_1_3_4_11_2","doi-asserted-by":"publisher","DOI":"10.1097\/QCO.0b013e328332e672"},{"key":"e_1_3_4_12_2","doi-asserted-by":"publisher","DOI":"10.1038\/s41564-023-01369-z"},{"key":"e_1_3_4_13_2","doi-asserted-by":"publisher","DOI":"10.1093\/jac\/dkx038"},{"key":"e_1_3_4_14_2","doi-asserted-by":"publisher","DOI":"10.1038\/s41467-018-02875-z"},{"key":"e_1_3_4_15_2","doi-asserted-by":"publisher","DOI":"10.1128\/AAC.38.2.374"},{"key":"e_1_3_4_16_2","doi-asserted-by":"publisher","DOI":"10.1038\/nmicrobiol.2017.28"},{"key":"e_1_3_4_17_2","doi-asserted-by":"publisher","DOI":"10.1021\/acs.chemrev.0c00922"},{"key":"e_1_3_4_18_2","doi-asserted-by":"publisher","DOI":"10.3390\/cells8010038"},{"key":"e_1_3_4_19_2","doi-asserted-by":"publisher","DOI":"10.3389\/fmicb.2016.01552"},{"key":"e_1_3_4_20_2","doi-asserted-by":"publisher","DOI":"10.3389\/fphar.2021.720726"},{"key":"e_1_3_4_21_2","doi-asserted-by":"publisher","DOI":"10.3389\/fcimb.2022.883839"},{"key":"e_1_3_4_22_2","doi-asserted-by":"publisher","DOI":"10.1186\/s13065-018-0466-6"},{"key":"e_1_3_4_23_2","doi-asserted-by":"publisher","DOI":"10.1016\/j.nmni.2021.100861"},{"key":"e_1_3_4_24_2","doi-asserted-by":"publisher","DOI":"10.1007\/s00203-021-02248-z"},{"key":"e_1_3_4_25_2","doi-asserted-by":"publisher","DOI":"10.1126\/scitranslmed.abn3758"},{"key":"e_1_3_4_26_2","doi-asserted-by":"publisher","DOI":"10.1126\/science.8153625"},{"key":"e_1_3_4_27_2","doi-asserted-by":"publisher","DOI":"10.1038\/s41564-020-0723-z"},{"key":"e_1_3_4_28_2","doi-asserted-by":"publisher","DOI":"10.1128\/AAC.00497-09"},{"key":"e_1_3_4_29_2","doi-asserted-by":"publisher","DOI":"10.7554\/eLife.65836"},{"key":"e_1_3_4_30_2","volume-title":"WHO bacterial priority pathogens list, 2024: bacterial pathogens of public health importance to guide research, development and strategies to prevent and control antimicrobial resistance","author":"WHO","year":"2024","unstructured":"WHO. 2024. WHO bacterial priority pathogens list, 2024: bacterial pathogens of public health importance to guide research, development and strategies to prevent and control antimicrobial resistance. World Health Organization, Geneva."},{"key":"e_1_3_4_31_2","doi-asserted-by":"publisher","DOI":"10.3389\/fmicb.2019.01703"},{"key":"e_1_3_4_32_2","doi-asserted-by":"publisher","DOI":"10.1039\/C5MD00503E"},{"key":"e_1_3_4_33_2","doi-asserted-by":"publisher","DOI":"10.1038\/s41467-017-02149-0"},{"key":"e_1_3_4_34_2","doi-asserted-by":"publisher","DOI":"10.1021\/acs.jcim.0c01051"},{"key":"e_1_3_4_35_2","doi-asserted-by":"publisher","DOI":"10.1016\/j.jmb.2020.04.022"},{"key":"e_1_3_4_36_2","doi-asserted-by":"publisher","DOI":"10.1016\/j.bpc.2015.02.001"},{"key":"e_1_3_4_37_2","doi-asserted-by":"publisher","DOI":"10.1007\/s10863-021-09906-3"},{"key":"e_1_3_4_38_2","doi-asserted-by":"publisher","DOI":"10.3389\/fphar.2022.953982"},{"key":"e_1_3_4_39_2","doi-asserted-by":"publisher","DOI":"10.3389\/fcimb.2014.00112"},{"key":"e_1_3_4_40_2","doi-asserted-by":"publisher","DOI":"10.3390\/molecules201018923"},{"key":"e_1_3_4_41_2","doi-asserted-by":"publisher","DOI":"10.1021\/cb500086e"},{"key":"e_1_3_4_42_2","doi-asserted-by":"publisher","DOI":"10.1136\/jitc-2022-006602"},{"key":"e_1_3_4_43_2","doi-asserted-by":"publisher","DOI":"10.1128\/JB.00498-21"},{"key":"e_1_3_4_44_2","doi-asserted-by":"publisher","DOI":"10.1016\/j.ebiom.2015.05.021"},{"key":"e_1_3_4_45_2","doi-asserted-by":"publisher","DOI":"10.3390\/antibiotics9060325"},{"key":"e_1_3_4_46_2","doi-asserted-by":"publisher","DOI":"10.3390\/pharmaceutics13111849"},{"key":"e_1_3_4_47_2","doi-asserted-by":"publisher","DOI":"10.1038\/s41579-022-00767-0"},{"key":"e_1_3_4_48_2","doi-asserted-by":"publisher","DOI":"10.1038\/s41522-018-0056-3"},{"key":"e_1_3_4_49_2","doi-asserted-by":"publisher","DOI":"10.1128\/mBio.00198-12"},{"key":"e_1_3_4_50_2","doi-asserted-by":"publisher","DOI":"10.1016\/j.ijantimicag.2017.01.005"},{"key":"e_1_3_4_51_2","doi-asserted-by":"publisher","DOI":"10.1093\/cid\/ciz826"},{"key":"e_1_3_4_52_2","doi-asserted-by":"publisher","DOI":"10.3390\/antibiotics12081261"},{"key":"e_1_3_4_53_2","doi-asserted-by":"publisher","DOI":"10.1038\/s41598-022-17083-5"},{"key":"e_1_3_4_54_2","doi-asserted-by":"publisher","DOI":"10.1128\/spectrum.03687-23"},{"key":"e_1_3_4_55_2","doi-asserted-by":"publisher","DOI":"10.1016\/j.retram.2020.01.001"},{"key":"e_1_3_4_56_2","doi-asserted-by":"publisher","DOI":"10.1016\/j.bcp.2024.116607"},{"key":"e_1_3_4_57_2","volume-title":"CLSI document M07-A10","author":"CLSI (Clinical and Laboratory Standards Institute)","year":"2015","unstructured":"CLSI (Clinical and Laboratory Standards Institute). 2015. Methods for dilution antimicrobial susceptibility tests for bacteria that grow aerobically; Approved standard. In CLSI document M07-A10, 10th ed","edition":"10"},{"key":"e_1_3_4_58_2","doi-asserted-by":"publisher","DOI":"10.1093\/jac\/48.suppl_1.5"},{"key":"e_1_3_4_59_2","doi-asserted-by":"publisher","DOI":"10.3389\/fmicb.2015.00165"},{"key":"e_1_3_4_60_2","doi-asserted-by":"publisher","DOI":"10.1128\/AAC.02593-18"},{"key":"e_1_3_4_61_2","doi-asserted-by":"publisher","DOI":"10.1093\/jac\/11.5.427"},{"key":"e_1_3_4_62_2","doi-asserted-by":"publisher","DOI":"10.1021\/acs.jcim.1c01514"},{"key":"e_1_3_4_63_2","doi-asserted-by":"publisher","DOI":"10.1002\/jcc.20945"},{"key":"e_1_3_4_64_2","doi-asserted-by":"publisher","DOI":"10.1016\/j.apsadv.2021.100112"},{"key":"e_1_3_4_65_2","doi-asserted-by":"publisher","DOI":"10.1074\/jbc.M110.209536"},{"key":"e_1_3_4_66_2","doi-asserted-by":"publisher","DOI":"10.1016\/j.apsusc.2020.146538"},{"key":"e_1_3_4_67_2","doi-asserted-by":"publisher","DOI":"10.1111\/j.1365-2672.2012.05337.x"},{"key":"e_1_3_4_68_2","doi-asserted-by":"publisher","DOI":"10.1016\/j.biochi.2012.12.004"},{"key":"e_1_3_4_69_2","doi-asserted-by":"publisher","DOI":"10.1099\/00221287-146-10-2395"}],"container-title":["mBio"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/journals.asm.org\/doi\/pdf\/10.1128\/mbio.02314-25","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/journals.asm.org\/doi\/pdf\/10.1128\/mbio.02314-25","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,2,11]],"date-time":"2026-02-11T14:04:23Z","timestamp":1770818663000},"score":1,"resource":{"primary":{"URL":"https:\/\/journals.asm.org\/doi\/10.1128\/mbio.02314-25"}},"subtitle":[],"editor":[{"given":"Lori Delorme","family":"Banks","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"editor"}]}],"short-title":[],"issued":{"date-parts":[[2026,2,11]]},"references-count":68,"journal-issue":{"issue":"2","published-print":{"date-parts":[[2026,2,11]]}},"alternative-id":["10.1128\/mbio.02314-25"],"URL":"https:\/\/doi.org\/10.1128\/mbio.02314-25","relation":{},"ISSN":["2150-7511"],"issn-type":[{"value":"2150-7511","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,2,11]]},"assertion":[{"value":"2025-07-29","order":0,"name":"received","label":"Received","group":{"name":"publication_history","label":"Publication History"}},{"value":"2025-12-02","order":2,"name":"accepted","label":"Accepted","group":{"name":"publication_history","label":"Publication History"}},{"value":"2025-12-29","order":3,"name":"published","label":"Published","group":{"name":"publication_history","label":"Publication History"}}],"article-number":"e02314-25"}}